BTSG brightspringhealth.com EV/EBITDA Multiple

BrightSpring - graphic logo of issuer BTSG

The change in the EV/EBITDA ratio for BrightSpring Health (BTSG) reflects the company's valuation dynamics, where 20.68 shows the current value of the metric. This growth is driven by the high demand for home healthcare services for chronic pathologies. Efficiency is increasing through the digitalization of document workflows and sustainable logistics. Meanwhile, John Russo's management aims to consolidate the market and reduce debt leverage by developing its own pharmacy network.

BTSG (BrightSpring Corp) Enterprise Value to Operating Income Before Depreciation Ratio history from 11/23/2025 to 11/10/2026
Original product of BrightSpring Health Services

BrightSpring Health (BTSG) dominance in the complex patient rehabilitation sector, driven by the aging US population, makes the EV/EBITDA multiple trend a key tool for monitoring debt load. The ratio of enterprise value to operating profit allows for an assessment of the company's real price inclusive of debt, where a declining metric amid rising liabilities signals hidden risks rather than an undervalued asset.